Short-chain fatty acids stimulate angiopoietin-like 4 synthesis in human colon adenocarcinoma cells by activating peroxisome proliferator-activated receptor γ S Alex, K Lange, T Amolo, JS Grinstead, AK Haakonsson, E Szalowska, ...
Molecular and cellular biology 33 (7), 1303-1316, 2013
288 2013 TRIM24 is an oncogenic transcriptional activator in prostate cancer AC Groner, L Cato, J de Tribolet-Hardy, T Bernasocchi, H Janouskova, ...
Cancer cell 29 (6), 846-858, 2016
254 2016 Allele-specific chromatin recruitment and therapeutic vulnerabilities of ESR1 activating mutations R Jeselsohn, JS Bergholz, M Pun, MI Cornwell, W Liu, A Nardone, T Xiao, ...
Cancer cell 33 (2), 173-186. e5, 2018
237 2018 Selective mineralocorticoid receptor cofactor modulation as molecular basis for finerenone’s antifibrotic activity J Grune, N Beyhoff, E Smeir, R Chudek, A Blumrich, Z Ban, S Brix, IR Betz, ...
Hypertension 71 (4), 599-608, 2018
196 2018 Therapeutic ligands antagonize estrogen receptor function by impairing its mobility J Guan, W Zhou, M Hafner, RA Blake, C Chalouni, IP Chen, T De Bruyn, ...
Cell 178 (4), 949-963. e18, 2019
154 2019 ARv7 represses tumor-suppressor genes in castration-resistant prostate cancer L Cato, J de Tribolet-Hardy, I Lee, JT Rottenberg, I Coleman, D Melchers, ...
Cancer cell 35 (3), 401-413. e6, 2019
153 2019 Resveratrol modulates the inflammatory response via an estrogen receptor-signal integration network JC Nwachukwu, S Srinivasan, NE Bruno, AA Parent, TS Hughes, ...
elife 3, e02057, 2014
142 2014 The nuclear receptor PPARγ controls progressive macrophage polarization as a ligand-insensitive epigenomic ratchet of transcriptional memory B Daniel, G Nagy, Z Czimmerer, A Horvath, DW Hammers, ...
Immunity 49 (4), 615-626. e6, 2018
141 2018 Differential targeting of brain stress circuits with a selective glucocorticoid receptor modulator I Zalachoras, R Houtman, E Atucha, R Devos, AMI Tijssen, P Hu, ...
Proceedings of the National Academy of Sciences 110 (19), 7910-7915, 2013
134 2013 The effect of F877L and T878A mutations on androgen receptor response to enzalutamide S Prekovic, ME van Royen, ARD Voet, B Geverts, R Houtman, D Melchers, ...
Molecular cancer therapeutics 15 (7), 1702-1712, 2016
105 2016 Discovery of Selective Estrogen Receptor Covalent Antagonists for the Treatment of ERαWT and ERαMUT Breast Cancer X Puyang, C Furman, GZ Zheng, ZJ Wu, D Banka, K Aithal, S Agoulnik, ...
Cancer discovery 8 (9), 1176-1193, 2018
94 2018 The SERM/SERD bazedoxifene disrupts ESR1 helix 12 to overcome acquired hormone resistance in breast cancer cells SW Fanning, R Jeselsohn, V Dharmarajan, CG Mayne, M Karimi, ...
Elife 7, e37161, 2018
89 2018 Differential in Vitro Biological Action, Coregulator Interactions, and Molecular Dynamic Analysis of Bisphenol A (BPA), BPAF, and BPS Ligand–ER Y Li, L Perera, LA Coons, KA Burns, J Tyler Ramsey, KE Pelch, ...
Environmental Health Perspectives 126 (1), 017012, 2018
86 2018 Nuclear receptor-coregulator interaction profiling identifies TRIP3 as a novel peroxisome proliferator-activated receptor γ cofactor A Koppen, R Houtman, D Pijnenburg, EH Jeninga, R Ruijtenbeek, ...
Molecular & Cellular Proteomics 8 (10), 2212-2226, 2009
80 2009 Estrogenic effects in the immature rat uterus after dietary exposure to ethinylestradiol and zearalenone using a systems biology approach M Heneweer, R Houtman, J Poortman, M Groot, C Maliepaard, ...
Toxicological sciences 99 (1), 303-314, 2007
74 2007 Lung proteome alterations in a mouse model for nonallergic asthma R Houtman, J Krijgsveld, M Kool, EP Romijn, FA Redegeld, FP Nijkamp, ...
Proteomics 3 (10), 2008-2018, 2003
68 2003 The AF-1-deficient estrogen receptor ERα46 isoform is frequently expressed in human breast tumors E Chantalat, F Boudou, H Laurell, G Palierne, R Houtman, D Melchers, ...
Breast Cancer Research 18, 1-16, 2016
65 2016 Binding of bisphenol A, bisphenol AF, and bisphenol S on the androgen receptor: Coregulator recruitment and stimulation of potential interaction sites L Perera, Y Li, LA Coons, R Houtman, R van Beuningen, B Goodwin, ...
Toxicology in Vitro 44, 287-302, 2017
58 2017 A mixed glucocorticoid/mineralocorticoid selective modulator with dominant antagonism in the male rat brain E Atucha, I Zalachoras, JK van den Heuvel, LTCM van Weert, D Melchers, ...
Endocrinology 156 (11), 4105-4114, 2015
56 2015 Orally bioavailable androgen receptor degrader, potential next-generation therapeutic for enzalutamide-resistant prostate cancer S Ponnusamy, Y He, DJ Hwang, T Thiyagarajan, R Houtman, ...
Clinical Cancer Research 25 (22), 6764-6780, 2019
55 2019 